1 Study Coverage
    1.1 Efavirenz Product Introduction
    1.2 Market by Type
        1.2.1 Global Efavirenz Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Single Efavirenz
        1.2.3 Two-drug combination
        1.2.4 Three-drug combination
    1.3 Market by Application
        1.3.1 Global Efavirenz Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Adults
        1.3.3 Children
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Efavirenz Sales Estimates and Forecasts 2017-2028
    2.2 Global Efavirenz Revenue Estimates and Forecasts 2017-2028
    2.3 Global Efavirenz Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Efavirenz Sales by Region
        2.4.1 Global Efavirenz Sales by Region (2017-2022)
        2.4.2 Global Sales Efavirenz by Region (2023-2028)
    2.5 Global Efavirenz Revenue by Region
        2.5.1 Global Efavirenz Revenue by Region (2017-2022)
        2.5.2 Global Efavirenz Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Efavirenz Sales by Manufacturers
        3.1.1 Global Top Efavirenz Manufacturers by Sales (2017-2022)
        3.1.2 Global Efavirenz Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Efavirenz in 2021
    3.2 Global Efavirenz Revenue by Manufacturers
        3.2.1 Global Efavirenz Revenue by Manufacturers (2017-2022)
        3.2.2 Global Efavirenz Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Efavirenz Revenue in 2021
    3.3 Global Efavirenz Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Efavirenz Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Efavirenz Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Efavirenz Sales by Type
        4.1.1 Global Efavirenz Historical Sales by Type (2017-2022)
        4.1.2 Global Efavirenz Forecasted Sales by Type (2023-2028)
        4.1.3 Global Efavirenz Sales Market Share by Type (2017-2028)
    4.2 Global Efavirenz Revenue by Type
        4.2.1 Global Efavirenz Historical Revenue by Type (2017-2022)
        4.2.2 Global Efavirenz Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Efavirenz Revenue Market Share by Type (2017-2028)
    4.3 Global Efavirenz Price by Type
        4.3.1 Global Efavirenz Price by Type (2017-2022)
        4.3.2 Global Efavirenz Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Efavirenz Sales by Application
        5.1.1 Global Efavirenz Historical Sales by Application (2017-2022)
        5.1.2 Global Efavirenz Forecasted Sales by Application (2023-2028)
        5.1.3 Global Efavirenz Sales Market Share by Application (2017-2028)
    5.2 Global Efavirenz Revenue by Application
        5.2.1 Global Efavirenz Historical Revenue by Application (2017-2022)
        5.2.2 Global Efavirenz Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Efavirenz Revenue Market Share by Application (2017-2028)
    5.3 Global Efavirenz Price by Application
        5.3.1 Global Efavirenz Price by Application (2017-2022)
        5.3.2 Global Efavirenz Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Efavirenz Market Size by Type
        6.1.1 North America Efavirenz Sales by Type (2017-2028)
        6.1.2 North America Efavirenz Revenue by Type (2017-2028)
    6.2 North America Efavirenz Market Size by Application
        6.2.1 North America Efavirenz Sales by Application (2017-2028)
        6.2.2 North America Efavirenz Revenue by Application (2017-2028)
    6.3 North America Efavirenz Market Size by Country
        6.3.1 North America Efavirenz Sales by Country (2017-2028)
        6.3.2 North America Efavirenz Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Efavirenz Market Size by Type
        7.1.1 Europe Efavirenz Sales by Type (2017-2028)
        7.1.2 Europe Efavirenz Revenue by Type (2017-2028)
    7.2 Europe Efavirenz Market Size by Application
        7.2.1 Europe Efavirenz Sales by Application (2017-2028)
        7.2.2 Europe Efavirenz Revenue by Application (2017-2028)
    7.3 Europe Efavirenz Market Size by Country
        7.3.1 Europe Efavirenz Sales by Country (2017-2028)
        7.3.2 Europe Efavirenz Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Efavirenz Market Size by Type
        8.1.1 Asia Pacific Efavirenz Sales by Type (2017-2028)
        8.1.2 Asia Pacific Efavirenz Revenue by Type (2017-2028)
    8.2 Asia Pacific Efavirenz Market Size by Application
        8.2.1 Asia Pacific Efavirenz Sales by Application (2017-2028)
        8.2.2 Asia Pacific Efavirenz Revenue by Application (2017-2028)
    8.3 Asia Pacific Efavirenz Market Size by Region
        8.3.1 Asia Pacific Efavirenz Sales by Region (2017-2028)
        8.3.2 Asia Pacific Efavirenz Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Efavirenz Market Size by Type
        9.1.1 Latin America Efavirenz Sales by Type (2017-2028)
        9.1.2 Latin America Efavirenz Revenue by Type (2017-2028)
    9.2 Latin America Efavirenz Market Size by Application
        9.2.1 Latin America Efavirenz Sales by Application (2017-2028)
        9.2.2 Latin America Efavirenz Revenue by Application (2017-2028)
    9.3 Latin America Efavirenz Market Size by Country
        9.3.1 Latin America Efavirenz Sales by Country (2017-2028)
        9.3.2 Latin America Efavirenz Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Efavirenz Market Size by Type
        10.1.1 Middle East and Africa Efavirenz Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Efavirenz Revenue by Type (2017-2028)
    10.2 Middle East and Africa Efavirenz Market Size by Application
        10.2.1 Middle East and Africa Efavirenz Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Efavirenz Revenue by Application (2017-2028)
    10.3 Middle East and Africa Efavirenz Market Size by Country
        10.3.1 Middle East and Africa Efavirenz Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Efavirenz Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Bristol-Myers Squibb
        11.1.1 Bristol-Myers Squibb Corporation Information
        11.1.2 Bristol-Myers Squibb Overview
        11.1.3 Bristol-Myers Squibb Efavirenz Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Bristol-Myers Squibb Efavirenz Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Bristol-Myers Squibb Recent Developments
    11.2 Teva
        11.2.1 Teva Corporation Information
        11.2.2 Teva Overview
        11.2.3 Teva Efavirenz Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Teva Efavirenz Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Teva Recent Developments
    11.3 Mylan
        11.3.1 Mylan Corporation Information
        11.3.2 Mylan Overview
        11.3.3 Mylan Efavirenz Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Mylan Efavirenz Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Mylan Recent Developments
    11.4 Aurobindo Pharma
        11.4.1 Aurobindo Pharma Corporation Information
        11.4.2 Aurobindo Pharma Overview
        11.4.3 Aurobindo Pharma Efavirenz Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Aurobindo Pharma Efavirenz Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Aurobindo Pharma Recent Developments
    11.5 Cipla
        11.5.1 Cipla Corporation Information
        11.5.2 Cipla Overview
        11.5.3 Cipla Efavirenz Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Cipla Efavirenz Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Cipla Recent Developments
    11.6 Macleods Pharmaceuticals
        11.6.1 Macleods Pharmaceuticals Corporation Information
        11.6.2 Macleods Pharmaceuticals Overview
        11.6.3 Macleods Pharmaceuticals Efavirenz Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Macleods Pharmaceuticals Efavirenz Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Macleods Pharmaceuticals Recent Developments
    11.7 Hetero
        11.7.1 Hetero Corporation Information
        11.7.2 Hetero Overview
        11.7.3 Hetero Efavirenz Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Hetero Efavirenz Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Hetero Recent Developments
    11.8 Strides Pharma
        11.8.1 Strides Pharma Corporation Information
        11.8.2 Strides Pharma Overview
        11.8.3 Strides Pharma Efavirenz Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Strides Pharma Efavirenz Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Strides Pharma Recent Developments
    11.9 Gilead Sciences
        11.9.1 Gilead Sciences Corporation Information
        11.9.2 Gilead Sciences Overview
        11.9.3 Gilead Sciences Efavirenz Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Gilead Sciences Efavirenz Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Gilead Sciences Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Efavirenz Industry Chain Analysis
    12.2 Efavirenz Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Efavirenz Production Mode & Process
    12.4 Efavirenz Sales and Marketing
        12.4.1 Efavirenz Sales Channels
        12.4.2 Efavirenz Distributors
    12.5 Efavirenz Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Efavirenz Industry Trends
    13.2 Efavirenz Market Drivers
    13.3 Efavirenz Market Challenges
    13.4 Efavirenz Market Restraints
14 Key Findings in The Global Efavirenz Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Efavirenz Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Single Efavirenz
    Table 3. Major Manufacturers of Two-drug combination
    Table 4. Major Manufacturers of Three-drug combination
    Table 5. Global Efavirenz Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Efavirenz Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Efavirenz Sales by Region (2017-2022) & (K Units)
    Table 8. Global Efavirenz Sales Market Share by Region (2017-2022)
    Table 9. Global Efavirenz Sales by Region (2023-2028) & (K Units)
    Table 10. Global Efavirenz Sales Market Share by Region (2023-2028)
    Table 11. Global Efavirenz Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Efavirenz Revenue Market Share by Region (2017-2022)
    Table 13. Global Efavirenz Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Efavirenz Revenue Market Share by Region (2023-2028)
    Table 15. Global Efavirenz Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Efavirenz Sales Share by Manufacturers (2017-2022)
    Table 17. Global Efavirenz Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Efavirenz Revenue Share by Manufacturers (2017-2022)
    Table 19. Efavirenz Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Efavirenz Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Efavirenz by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Efavirenz as of 2021)
    Table 22. Efavirenz Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Efavirenz Product Offered
    Table 24. Date of Manufacturers Enter into Efavirenz Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Efavirenz Sales by Type (2017-2022) & (K Units)
    Table 27. Global Efavirenz Sales by Type (2023-2028) & (K Units)
    Table 28. Global Efavirenz Sales Share by Type (2017-2022)
    Table 29. Global Efavirenz Sales Share by Type (2023-2028)
    Table 30. Global Efavirenz Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Efavirenz Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Efavirenz Revenue Share by Type (2017-2022)
    Table 33. Global Efavirenz Revenue Share by Type (2023-2028)
    Table 34. Efavirenz Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Efavirenz Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Efavirenz Sales by Application (2017-2022) & (K Units)
    Table 37. Global Efavirenz Sales by Application (2023-2028) & (K Units)
    Table 38. Global Efavirenz Sales Share by Application (2017-2022)
    Table 39. Global Efavirenz Sales Share by Application (2023-2028)
    Table 40. Global Efavirenz Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Efavirenz Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Efavirenz Revenue Share by Application (2017-2022)
    Table 43. Global Efavirenz Revenue Share by Application (2023-2028)
    Table 44. Efavirenz Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Efavirenz Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Efavirenz Sales by Type (2017-2022) & (K Units)
    Table 47. North America Efavirenz Sales by Type (2023-2028) & (K Units)
    Table 48. North America Efavirenz Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Efavirenz Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Efavirenz Sales by Application (2017-2022) & (K Units)
    Table 51. North America Efavirenz Sales by Application (2023-2028) & (K Units)
    Table 52. North America Efavirenz Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Efavirenz Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Efavirenz Sales by Country (2017-2022) & (K Units)
    Table 55. North America Efavirenz Sales by Country (2023-2028) & (K Units)
    Table 56. North America Efavirenz Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Efavirenz Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Efavirenz Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Efavirenz Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Efavirenz Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Efavirenz Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Efavirenz Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Efavirenz Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Efavirenz Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Efavirenz Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Efavirenz Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Efavirenz Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Efavirenz Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Efavirenz Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Efavirenz Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Efavirenz Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Efavirenz Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Efavirenz Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Efavirenz Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Efavirenz Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Efavirenz Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Efavirenz Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Efavirenz Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Efavirenz Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Efavirenz Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Efavirenz Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Efavirenz Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Efavirenz Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Efavirenz Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Efavirenz Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Efavirenz Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Efavirenz Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Efavirenz Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Efavirenz Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Efavirenz Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Efavirenz Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Efavirenz Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Efavirenz Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Efavirenz Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Efavirenz Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Efavirenz Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Efavirenz Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Efavirenz Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Efavirenz Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Efavirenz Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Efavirenz Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Efavirenz Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Efavirenz Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Efavirenz Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Efavirenz Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Bristol-Myers Squibb Corporation Information
    Table 107. Bristol-Myers Squibb Description and Major Businesses
    Table 108. Bristol-Myers Squibb Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Bristol-Myers Squibb Efavirenz Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Bristol-Myers Squibb Recent Developments
    Table 111. Teva Corporation Information
    Table 112. Teva Description and Major Businesses
    Table 113. Teva Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Teva Efavirenz Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Teva Recent Developments
    Table 116. Mylan Corporation Information
    Table 117. Mylan Description and Major Businesses
    Table 118. Mylan Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Mylan Efavirenz Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Mylan Recent Developments
    Table 121. Aurobindo Pharma Corporation Information
    Table 122. Aurobindo Pharma Description and Major Businesses
    Table 123. Aurobindo Pharma Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Aurobindo Pharma Efavirenz Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Aurobindo Pharma Recent Developments
    Table 126. Cipla Corporation Information
    Table 127. Cipla Description and Major Businesses
    Table 128. Cipla Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Cipla Efavirenz Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Cipla Recent Developments
    Table 131. Macleods Pharmaceuticals Corporation Information
    Table 132. Macleods Pharmaceuticals Description and Major Businesses
    Table 133. Macleods Pharmaceuticals Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Macleods Pharmaceuticals Efavirenz Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Macleods Pharmaceuticals Recent Developments
    Table 136. Hetero Corporation Information
    Table 137. Hetero Description and Major Businesses
    Table 138. Hetero Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Hetero Efavirenz Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Hetero Recent Developments
    Table 141. Strides Pharma Corporation Information
    Table 142. Strides Pharma Description and Major Businesses
    Table 143. Strides Pharma Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Strides Pharma Efavirenz Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Strides Pharma Recent Developments
    Table 146. Gilead Sciences Corporation Information
    Table 147. Gilead Sciences Description and Major Businesses
    Table 148. Gilead Sciences Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. Gilead Sciences Efavirenz Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Gilead Sciences Recent Developments
    Table 151. Key Raw Materials Lists
    Table 152. Raw Materials Key Suppliers Lists
    Table 153. Efavirenz Distributors List
    Table 154. Efavirenz Customers List
    Table 155. Efavirenz Market Trends
    Table 156. Efavirenz Market Drivers
    Table 157. Efavirenz Market Challenges
    Table 158. Efavirenz Market Restraints
    Table 159. Research Programs/Design for This Report
    Table 160. Key Data Information from Secondary Sources
    Table 161. Key Data Information from Primary Sources
List of Figures
    Figure 1. Efavirenz Product Picture
    Figure 3. Global Efavirenz Market Share by Type in 2021 & 2028
    Figure 3. Single Efavirenz Product Picture
    Figure 4. Two-drug combination Product Picture
    Figure 5. Three-drug combination Product Picture
    Figure 6. Global Efavirenz Market Share by Application in 2021 & 2028
    Figure 7. Adults
    Figure 8. Children
    Figure 9. Efavirenz Report Years Considered
    Figure 10. Global Efavirenz Sales 2017-2028 (K Units)
    Figure 11. Global Efavirenz Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Efavirenz Revenue 2017-2028 (US$ Million)
    Figure 13. Global Efavirenz Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Efavirenz Sales Market Share by Region (2017-2022)
    Figure 15. Global Efavirenz Sales Market Share by Region (2023-2028)
    Figure 16. North America Efavirenz Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Efavirenz Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Efavirenz Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Efavirenz Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Efavirenz Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Efavirenz Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Efavirenz Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Efavirenz Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Efavirenz Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Efavirenz Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Efavirenz Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Efavirenz in the World: Market Share by Efavirenz Revenue in 2021
    Figure 28. Global Efavirenz Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Efavirenz Sales Market Share by Type (2017-2028)
    Figure 30. Global Efavirenz Revenue Market Share by Type (2017-2028)
    Figure 31. Global Efavirenz Sales Market Share by Application (2017-2028)
    Figure 32. Global Efavirenz Revenue Market Share by Application (2017-2028)
    Figure 33. North America Efavirenz Sales Market Share by Type (2017-2028)
    Figure 34. North America Efavirenz Revenue Market Share by Type (2017-2028)
    Figure 35. North America Efavirenz Sales Market Share by Application (2017-2028)
    Figure 36. North America Efavirenz Revenue Market Share by Application (2017-2028)
    Figure 37. North America Efavirenz Sales Share by Country (2017-2028)
    Figure 38. North America Efavirenz Revenue Share by Country (2017-2028)
    Figure 39. U.S. Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Efavirenz Sales Market Share by Type (2017-2028)
    Figure 42. Europe Efavirenz Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Efavirenz Sales Market Share by Application (2017-2028)
    Figure 44. Europe Efavirenz Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Efavirenz Sales Share by Country (2017-2028)
    Figure 46. Europe Efavirenz Revenue Share by Country (2017-2028)
    Figure 47. Germany Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 48. France Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Efavirenz Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Efavirenz Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Efavirenz Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Efavirenz Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Efavirenz Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Efavirenz Revenue Share by Region (2017-2028)
    Figure 58. China Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 61. India Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Efavirenz Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Efavirenz Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Efavirenz Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Efavirenz Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Efavirenz Sales Share by Country (2017-2028)
    Figure 73. Latin America Efavirenz Revenue Share by Country (2017-2028)
    Figure 74. Mexico Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Efavirenz Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Efavirenz Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Efavirenz Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Efavirenz Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Efavirenz Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Efavirenz Revenue Share by Country (2017-2028)
    Figure 83. Turkey Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Efavirenz Revenue (2017-2028) & (US$ Million)
    Figure 86. Efavirenz Value Chain
    Figure 87. Efavirenz Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed